Because of the high obesity-related CHD risk in T2DM women, the aim of this study was to explore the relationship between resistin levels and major risk factors, including inflammatory and endothelial dysfunction markers, in overweight/obese T2DM, with and without established CHD, and in a group of women without T2DM. The gene discussed is RETN; the disease is Obesity.